meningitis B
Showing 1 - 25 of >10,000
Cryptococcal Meningitis Trial in Kampala (MAT2203, Amphotericin B)
Active, not recruiting
- Cryptococcal Meningitis
- MAT2203
- Amphotericin B
-
Kampala, UgandaInfectious Disease Institute
Nov 16, 2022
Cryptococcal Meningitis Trial (MAT2203, Amphotericin B)
Not yet recruiting
- Cryptococcal Meningitis
- MAT2203
- Amphotericin B
- (no location specified)
Sep 12, 2022
Cryptococcal Meningitis Trial in Beijing (Amphotericin B Colloidal Dispersion, flucytosine, fluconazole)
Not yet recruiting
- Cryptococcal Meningitis
- Amphotericin B Colloidal Dispersion
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2022
Amphotericin B With Flucytosine-Fluconazole Therapy for
Completed
- Cryptococcal Meningitis
- Amphotericin B 1 mg/kg 1 week & Flucytosine 100 mg/kg 1 week followed by Fluconazole 1200 mg/day 1 week
-
Yangon, MyanmarSpecialist hospital Mingalardon,Thakeyta and Waibargi,Yangon Gen
Apr 20, 2022
Meningitis, Meningococcal Trial in Korea, Republic of (rMenB+OMV NZ)
Not yet recruiting
- Meningitis, Meningococcal
- rMenB+OMV NZ
-
Anyang-Si, Gyeonggi-do, Korea, Republic of
- +6 more
Oct 27, 2023
Cryptococcal Meningitis, HIV Trial in Worldwide (Fluconazole, Amphotericin B)
Completed
- Cryptococcal Meningitis
- HIV Infections
- Fluconazole
- Amphotericin B
-
Los Angeles, California
- +9 more
Nov 2, 2021
Meningitis, Cryptococcal, HIV Trial in United States (Itraconazole, Flucytosine, Fluconazole)
Completed
- Meningitis, Cryptococcal
- HIV Infections
- Itraconazole
- +3 more
-
Los Angeles, California
- +23 more
Oct 26, 2021
Meningitis, Cryptococcal, HIV Trial in Puerto Rico, United States (Flucytosine, Fluconazole, Amphotericin B)
Completed
- Meningitis, Cryptococcal
- HIV Infections
- Flucytosine
- +3 more
-
Birmingham, Alabama
- +13 more
Oct 27, 2021
Cryptococcal Meningitis, HIV/AIDS Trial in Zhenjiang (Voriconazole 200mg, amphotericin B deoxycholate (0.4-0.5mg/kg/d),
Unknown status
- Cryptococcal Meningitis
- HIV/AIDS
- Voriconazole 200mg
- +2 more
-
Zhenjiang, Hangzhou, ChinaLijun Xu
Jan 31, 2021
Meningoccocal Disease, Meningococcal Meningitis Trial in Hungary, Spain (Bexsero® vaccine (1 dose at study month zero), Bexsero®
Completed
- Meningoccocal Disease
- Meningococcal Meningitis
- Bexsero® vaccine (1 dose at study month zero)
- Bexsero® vaccine (2 doses 1 month apart)
-
Debrecen, Bajcsi Ut 32, Hungary
- +16 more
Nov 24, 2021
Tuberculosis, Meningeal Trial in Pune, Chennai, Lilongwe (High-dose: RIF, INH, PZA, EMB, High dose: RIF, INH, PZA, LEVO,
Completed
- Tuberculosis, Meningeal
- High-dose: RIF, INH, PZA, EMB
- +2 more
-
Pune, Maharashtra, India
- +2 more
Oct 27, 2021
Tuberculous Meningitis Trial (Xpert MTB/RIF)
Completed
- Tuberculous Meningitis
- Xpert MTB/RIF
- (no location specified)
Mar 12, 2023
Neurologic Complication, Neurosurgery Trial in Alexandria (Clindamycin 600 mg, standard regimen)
Recruiting
- Neurologic Complication
- Neurosurgery
- Clindamycin 600 mg
- standard regimen
-
Alexandria, EgyptAlexandria University Hospital
Sep 29, 2023
Meningitis Streptococcal, Hiv, Meningitis Trial in Ho Chi Minh City (Tamoxifen, Amphotericin B, Fluconazole)
Completed
- Meningitis Streptococcal
- +3 more
- Tamoxifen
- +2 more
-
Ho Chi Minh City, Vietnam
- +2 more
Nov 28, 2019
Observational Pilot Study With TachoSil as a Ventricular Sealant
Completed
- Intraventricular Neoplasm
-
Badalona, Barcelona, SpainHospital Universitari Germans Trias i Pujol
Feb 3, 2023
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Cryptococcal Meningitis Trial in Kampala (Single dose liposomal Amphotericin and Fluconazole, Fluconazole)
Recruiting
- Cryptococcal Meningitis
- Single dose liposomal Amphotericin and Fluconazole
- Fluconazole
-
Kampala, Ugandainfectious Disease Institute Kampala,Uganda
Dec 21, 2022
Tuberculous Meningitis Trial in Worldwide (Rifampicin (RIF), Isoniazid (INH), Linezolid (LZD))
Not yet recruiting
- Tuberculous Meningitis
- Rifampicin (RIF)
- +6 more
-
Porto Alegre, Brazil
- +9 more
Dec 14, 2022
Bacterial Meningitis, Fungal Meningitis, Implant Infection Trial in Berlin (D-lactate test, Standard diagnostic tests)
Recruiting
- Bacterial Meningitis
- +2 more
- D-lactate test
- Standard diagnostic tests
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Nov 22, 2021
Tuberculosis, Tuberculous Meningitis, Drug-Induced Liver Injury Trial in Jakarta, Ho Chi Minh City (Dexamethasone, Placebo)
Active, not recruiting
- Tuberculosis
- +4 more
- Dexamethasone
- Placebo
-
Jakarta, Indonesia
- +5 more
Jun 29, 2022
based Approaches for Improving Diagnosis of Childhood
Recruiting
- Tuberculous Meningitis
-
Cape Town, Western Cape, South AfricaStellenbosch University Immunology Research Group
May 16, 2022
Invasive Meningococcal Disease Trial in Poland, United States (Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria
Completed
- Invasive Meningococcal Disease
- Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV.
- +3 more
-
Birmingham, Alabama
- +12 more
Jun 11, 2020
Next Generation Sequencing Detection of Lyme Disease
Completed
- Lyme Disease
- +5 more
-
Setauket, New YorkClinical Research Center
Feb 23, 2022
Epidemic Meningitis Trial (MCV4, MSPV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- MSPV4
- (no location specified)
Aug 21, 2023
HIV, Meningitis Trial in Puerto Rico, United States (Quadrivalent meningococcal conjugate vaccine)
Completed
- HIV Infections
- Meningitis
- Quadrivalent meningococcal conjugate vaccine
-
Alhambra, California
- +36 more
Oct 29, 2021